苯并[a]菲啶 | 195-29-9

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 中文名称: 苯并[a]菲啶
• 英文名称: Benzophenanthridin
• 英文别名: benzo[a]phenanthridine
• CAS: 195-29-9
• 化学式: C₁₇H₁₁N
• 分子量: 229.281
• InChiKey: LOLQOGZQULMGDU-UHFFFAOYSA-N

物化性质

• 沸点：
  449.7±14.0 °C(Predicted)
• 密度：
  1.239±0.06 g/cm3(Predicted)
• 熔点：
  135 °C(Solv: ethanol (64-17-5))

计算性质

• 辛醇/水分配系数(LogP)：
  4.7
• 重原子数：
  18
• 可旋转键数：
  0
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  12.9
• 氢给体数：
  0
• 氢受体数：
  1

SDS

反应信息

• 作为反应物：
  描述：

  苯并[a]菲啶 、 碘甲烷 在 甲醇 作用下， 生成 N-methylbenzophenanthridone
  参考文献：
  名称：

  530.：酸对3：4-苯并芴酮进行扩环

  摘要：

  DOI：

  10.1039/jr9580002609
• 作为产物：
  描述：

  2-(1-萘基)苯甲醛 在 sodium acetate 、 lithium perchlorate 作用下， 以 甲醇 、 乙腈 为溶剂， 反应 2.0h， 生成 苯并[a]菲啶
  参考文献：
  名称：

  α-氨基氧基酸的电化学脱羧环化获得菲啶衍生物

  摘要：

  菲啶是一类重要的杂环化合物，存在于药物和天然产物中。在此，开发了一种高效的 α-氨基氧基酸电化学脱羧环化合成菲啶衍生物。该反应通过在无过渡金属和温和条件下从容易获得的材料中形成亚氨基自由基级联分子内环化进行。

  DOI：

  10.1002/asia.202101388

文献信息

• [EN] COMPOSITIONS AND METHODS FOR MAKING NOSCAPINE AND SYNTHESIS INTERMEDIATES THEREOF<br/>[FR] COMPOSITIONS ET PROCÉDÉS DE FABRICATION DE NOSCAPINE ET D'INTERMÉDIAIRES DE SYNTHÈSE DE CELLE-CI
  申请人：EPIMERON INC

  公开号：WO2015021561A1

  公开（公告）日：2015-02-19

  Methods for the manufacture of the therapeutic chemical compound noscapine and noscapine synthesis intermediates comprising contacting a noscapine pathway precursor selected from a first canadine derivative, a first papaveroxine derivative and narcotine hemiacetal with at least one of the enzymes selected from the group CYP82Y1, CYP82X1, AT1, CYP82X2, OMT, CXE1 and NOS.

  制备治疗化合物诺斯卡平和诺斯卡平合成中间体的方法包括将选自第一类肉桂碱衍生物、第一类罂粟碱衍生物和纳科汀半缩醛的诺斯卡平途径前体与来自CYP82Y1、CYP82X1、AT1、CYP82X2、OMT、CXE1和NOS组中至少一种酶中的至少一种接触。
• Co-administration of dopamine-receptor binding compounds
  申请人：Fernandes B. Prabhavathi

  公开号：US20070155720A1

  公开（公告）日：2007-07-05

  Methods for treating a patient having neurological, psychotic, and psychiatric disorders are described comprising the steps of administering to the patient an effective amount of a partial and/or full dopamine D 1 receptor agonist, and administering to the patient an effective amount of a dopamine D 2 receptor antagonist. Pharmaceutical compositions comprising a dopamine D 1 receptor agonist and a dopamine D 2 receptor antagonist are also described. The D 1 dopamine receptor agonist and the D 2 dopamine receptor antagonist can be administered to the patient in the same or in a different composition or compositions.

  描述了治疗患有神经、精神和精神障碍的患者的方法，包括向患者施用部分和/或全多巴胺D1受体激动剂的有效量，并向患者施用多巴胺D2受体拮抗剂的有效量。还描述了包含多巴胺D1受体激动剂和多巴胺D2受体拮抗剂的药物组合物。D1多巴胺受体激动剂和D2多巴胺受体拮抗剂可以以相同或不同的组合或组合物形式向患者施用。
• NOVEL SELF-ASSEMBLING DRUG AMPHIPHILES AND METHODS FOR SYNTHESIS AND USE
  申请人：The Johns Hopkins University

  公开号：US20140113875A1

  公开（公告）日：2014-04-24

  The present invention provides herein the design of monodisperse, amphiphilic anticancer drugs—which are now termed “drug amphiphiles” (DAs)—that can spontaneously associate into discrete, stable supramolecular nanostructures with the potential for self-delivery (no additional carriers are needed). The quantitative drug loading in the resulting nanostructures is ensured by the very nature of the molecular design. The DA is a composition comprising: D-L-PEP; wherein D is 1 to 4 hydrophobic drug molecules which can be the same or different; L is 1 to 4 biodegradable linkers which can be the same or different; and PEP is a peptide that can spontaneously associate into discrete, stable supramolecular nanostructures. In an alternate embodiment, the DA composition also comprises a targeting ligand (T). Methods of making DA molecules, as well as their use in treatment of disease are also provided.

  本发明在此提供了单分散、两性抗癌药物的设计，现在被称为“药物两性分子”（DAs），它们可以自发地聚集成离散、稳定的超分子纳米结构，具有自我传递的潜力（无需额外的载体）。由于分子设计的本质，所得纳米结构中的药物负载是定量的。DA是一种包括：D-L-PEP的组合物；其中D是1到4个疏水性药物分子，可以相同也可以不同；L是1到4个可降解的连接剂，可以相同也可以不同；PEP是一种可以自发地聚集成离散、稳定的超分子纳米结构的肽。在另一实施例中，DA组合物还包括一个靶向配体（T）。还提供了制备DA分子的方法，以及它们在治疗疾病中的用途。
• IRIDIUM COMPLEX COMPOUND, COMPOSITION CONTAINING THE COMPOUND AND SOLVENT, ORGANIC ELECTROLUMINESCENT ELEMENT CONTAINING THE COMPOUND, DISPLAY DEVICE, AND ILLUMINATION DEVICE
  申请人：MITSUBISHI CHEMICAL CORPORATION

  公开号：US20200317706A1

  公开（公告）日：2020-10-08

  Provided is an iridium complex compound represented by formula (1) below. [Ir is an iridium atom. C 1 to C 6 are carbon atoms. N 1 and N 2 are nitrogen atoms. R 1 to R 4 are each a hydrogen atom or a substituent. a to d are maximum integer numbers of possible substituents on rings Cy 1 to Cy 4 , respectively. m and n are each 1 or 2, and m+n=3. The ring Cy 1 is represented by formula (2) or (2′) below. The ring Cy 3 is an aromatic or heteroaromatic ring including the carbon atoms C 4 and C 5 . The ring Cy 4 is a heteroaromatic ring including the carbon atom C 6 and the nitrogen atom N 2 .]

  提供的铱配合物化合物的化学式如下所示。 [Ir 代表铱原子。C1到C6代表碳原子。N1和N2代表氮原子。R1到R4分别代表氢原子或取代基。a到d分别代表环Cy1到Cy4上可能的取代基的最大整数个数。m和n分别为1或2，且m+n=3。环Cy1的化学式如下所示。环Cy3是包括碳原子C4和C5的芳香或杂芳环。环Cy4是包括碳原子C6和氮原子N2的杂芳环。]
• Salutaridine reductase and morphine biosynthesis
  申请人：Leibniz-Institut für Pflanzenbiochemie (IPB)

  公开号：EP1837396A1

  公开（公告）日：2007-09-26

  Plants of the order Ranunculales, especially members of the species Papaver, accumulate a large variety of benzylisoquinoline alkaloids with about 2,500 structures. But only the opium poppy, Papaver somniferum, and Papaver setigerum, are able to produce morphinan alkaloids such as the analgesic morphine or the antitussive codeine. We investigated the molecular basis for this exceptional biosynthetic capability by comparison of alkaloid profiles with gene expression profiles between sixteen different Papaver species and identified one cDNA which exhibits very similar expression pattern to previously isolated cDNAs coding for enzymes in benzylisoquinoline biosynthesis and which showed the highest amino acid identity to reductases in menthol biosynthesis. When expressed, the protein encoded by this cDNA reduced the keto group of salutaridine yielding salutaridinol, an intermediate in morphine biosynthesis. The stereoisomer epi-salutaridinol was not formed. The encoded protein was identified as salutaridine reductase (SalR; EC 1.1.1.248) and it was found to belongs to the family of the short chain dehydrogenases / reductases.

  毛茛目植物，尤其是罂粟属物种，积累了大量的苯基异喹啉生物碱，约有2500种结构。但只有鸦片罂粟（Papaver somniferum）和刺毛罂粟（Papaver setigerum）等品种能够产生吗啡等镇痛药物吗啡类生物碱或镇咳药可待因。我们通过比较16种不同罂粟属植物的生物碱谱与基因表达谱，鉴定出一个cDNA，其表达模式与之前分离的编码苯基异喹啉生物合成酶的cDNA非常相似，并且与薄荷醇生物合成中的还原酶具有最高的氨基酸同源性。当表达时，这个cDNA编码的蛋白质将沙洛特啶的酮基还原为沙洛特啉醇，这是吗啡生物合成中的中间体。而对映异构体外沙洛特啉醇并未形成。这个编码的蛋白质被鉴定为沙洛特啶还原酶（SalR；EC 1.1.1.248），并且发现它属于短链脱氢酶/还原酶家族。